EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Central GHSR inverse agonism by a LEAP2 analog regulates thermometabolic and behavioral responses via catecholamine signaling

Isac Cardoso Dos Santos, Hanniely Thais Menezes Dos Santos, Juliana Vila Verde Ribeiro, João Pedro Maciel Machado Leite, Aline Rezende Ribeiro de Abreu, Michelle Mendanha Mendonça, Elder Sales da Silva, Eduardo Colombari, Gustavo Rodrigues Pedrino, Rodrigo Mello Gomes, James Fajemiroye, Paulo Marcelo Andrade Lima und 3 weitere

Physiology & Behavior · 2027-01 · 318 · 115521

DOI: 10.1016/j.physbeh.2026.115521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiology & Behavior, 2027-01. Verfasst von Isac Cardoso Dos Santos und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciências Fisiológicas, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, GO, Brazil. Hauptthemen laut MEDLINE: Signal Transduction, Catecholamines, Receptors, Ghrelin, Body Temperature Regulation. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Goiás.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liver-expressed antimicrobial peptide 2 (LEAP2) is an endogenous GHSR inverse agonist that antagonizes ghrelin-mediated signaling, thereby opposing several of the physiological actions elicited by ghrelin. Evidence indicates that GHSR participates in autonomic, cardiovascular, renal, and psychogenic regulation, interacts with dopaminergic signaling and interplays with adrenergic pathways during sympathetically driven hypertension. Here, we investigated whether catecholaminergic mechanisms mediate behavioral and thermometabolic effects evoked from central GHSR inverse agonism by a LEAP2 analog. METHODS: Adult male Wistar rats were systemically pretreated with either the tyrosine hydroxylase inhibitor α-methyl-para-tyrosine (AMPT; 200 mg/kg) or the non-selective dopamine receptor antagonist chlorpromazine (CLP; 2 mg/kg) and then centrally pretreated with LEAP2 analog (6 nmol) or vehicle. Rats were evaluated across a range of paradigms, including anxiety- and panic-like behaviors, open-field exploration, ingestive activity, treadmill performance with VO₂ recorders and infrared thermography of caudal heat dissipation. RESULTS: Central LEAP2 analog impaired the expression of anxiety- and panic-like responses and attenuated heat-conservation mechanisms triggered by aversion. Behavioral and food ingestive effects were largely dependent on dopaminergic receptor signaling, whereas thermoregulatory responses during exercise required the entire catecholaminergic pathways inhibited by AMPT. CONCLUSION: LEAP2 analog regulates specific behavioral and thermometabolic responses through neurobiological mechanisms involving catecholaminergic pathways and dopamine receptors, highlighting central GHSR as a potential pharmacological target for neuroendocrine defense mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionCatecholaminesReceptors, GhrelinBody Temperature RegulationAnimalsMaleRats, WistarRatsDopamine AntagonistsMotor Activityalpha-MethyltyrosineBody TemperatureExploratory BehaviorEnzyme InhibitorsEating

Stichwörter der Autor:innen

Dopamine receptorsGhrelin receptorLEAP2ThermoregulationTyrosine-catecholamine pathway

Substanzen

CatecholaminesReceptors, GhrelinDopamine Antagonistsalpha-MethyltyrosineEnzyme Inhibitors

Autor:innen und Institutionen

  • Departamento de Ciências Fisiológicas, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, GO, Brazil.
  • Escola de Nutrição, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil.
  • Departamento de Fisiologia e Patologia, Faculdade de Odontologia, Universidade Estadual Paulista, Araraquara, SP, Brazil.
  • Universidade Estadual de Goiás, Goiânia, GO, Brazil.
  • Departamento de Ciências Fisiológicas, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, GO, Brazil; Universidade Federal do Pampa, Uruguaiana, RS, Brazil.
  • Grupo de Estudos e Pesquisas em Epidemiologia e Saúde., Faculdade de Medicina, Universidade de Rio Verde, Campus Goiânia, GO, Brazil.

Förderung

  • Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de Goiás

Zitieren

APA

Dos Santos, I. C., Dos Santos, H. T. M., Ribeiro, J. V. V., Leite, J. P. M. M., de Abreu, A. R. R., Mendonça, M. M., da Silva, E. S., Colombari, E., Pedrino, G. R., Gomes, R. M., Fajemiroye, J., Lima, P. M. A., Perelló, M., Marques, S. M., & Xavier, C. H. (2027). Central GHSR inverse agonism by a LEAP2 analog regulates thermometabolic and behavioral responses via catecholamine signaling. Physiology & Behavior, 318, 115521. https://doi.org/10.1016/j.physbeh.2026.115521

Vancouver

Dos Santos IC, Dos Santos HTM, Ribeiro JVV, Leite JPMM, de Abreu ARR, Mendonça MM, et al. Central GHSR inverse agonism by a LEAP2 analog regulates thermometabolic and behavioral responses via catecholamine signaling. Physiology & Behavior. 2027;318:115521. doi:10.1016/j.physbeh.2026.115521

BibTeX
@article{DosSantos2027,
  author = {Dos Santos, Isac Cardoso and Dos Santos, Hanniely Thais Menezes and Ribeiro, Juliana Vila Verde and Leite, João Pedro Maciel Machado and de Abreu, Aline Rezende Ribeiro and Mendonça, Michelle Mendanha and da Silva, Elder Sales and Colombari, Eduardo and Pedrino, Gustavo Rodrigues and Gomes, Rodrigo Mello and Fajemiroye, James and Lima, Paulo Marcelo Andrade and Perelló, Mario and Marques, Stefanne Madalena and Xavier, Carlos Henrique},
  title = {Central GHSR inverse agonism by a LEAP2 analog regulates thermometabolic and behavioral responses via catecholamine signaling},
  journal = {Physiology & Behavior},
  year = {2027},
  volume = {318},
  pages = {115521},
  doi = {10.1016/j.physbeh.2026.115521}
}
Kostenlos starten →